Praxis Precision Medicines announced CEO Marcio Souza will participate in a virtual fireside chat hosted by Truist Securities analyst Joon Lee on August 5, 2025 at 10:00amEST. The company focuses on developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis uses genetic insights to discover treatments for rare and prevalent neurological disorders. They have a diverse CNS portfolio with four clinical-stage product candidates. For more information, visit their website and follow them on social media.

Read more at GlobeNewswire: Praxis Precision Medicines to Participate in Upcoming